Givlaari 189 mg/ml, Injektionslösung

7680678950017 CH-67895 Injektionslösung

Associated product:

GIVLAARI sol inj 189 mg/ml flac 1 ml
Givlaari 189 mg/ml, Injektionslösung
Givlaari 189 mg/ml, Injektionslösung
Givlaari 189 mg/ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/05/2025
Patient information leaflet
Français
15/05/2025
Patient information leaflet
Italien
15/05/2025
Summary of Product Characteristics
Allemand
15/05/2025
Summary of Product Characteristics
Français
15/05/2025
Summary of Product Characteristics
Italien
15/05/2025

Detailed composition

Substance Quantity Type Category
SOLU
189.0 MG Substance Wirkstoff (Principe actif)
SOLU
- Substance WIZUS
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
11.0 MG Substance HBESI

Reimbursement information

Public price
CHF 43049.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2023

Authorization holder

Alnylam Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
67895
Drug name
Givlaari, concentrate for solution for injection
Galenic form
LSINJ
ATC Code
A16AX
Authorization status
Z
Dispensing category
B
First authorization
29/03/2021
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Givlaari ist indiziert für die Behandlung einer akuten hepatischen Porphyrie (AHP) bei Erwachsenen und Jugendlichen ab 12 Jahren

Package details

Description (FR)
GIVLAARI sol inj 189 mg/ml flac 1 ml
Description (DE)
GIVLAARI Inj Lös 189 mg/ml Durchstf 1 ml
Market launch
29/03/2021
Narcotic (BTM)
No

Application methods

SUBC